A Central Nervous System Focused Treatment Approach for Frozen Shoulder
Primary Purpose
Adhesive Capsulitis of Shoulder, Frozen Shoulder
Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
CNS-focused treatment
Standard Care Treatment
Sponsored by
About this trial
This is an interventional treatment trial for Adhesive Capsulitis of Shoulder
Eligibility Criteria
Inclusion Criteria:
- Primary or idiopathic Frozen Shoulder (FS), defined as FS not associated with a systemic condition or history of injury
- greater than 50% reduction in passive external rotation when compared to the uninvolved shoulder or less than 30° of external rotation
- range of motion loss of greater than 25% in at least two movement planes in comparison to the uninvolved shoulder
- pain and restricted movement present for at least one month reaching a plateau or worsening
- normal shoulder X-rays (with the exception of osteopenia of the humeral head and calcific tendinosis)
Exclusion Criteria:
- Locked dislocations, arthritis, fractures or avascular necrosis on radiographs
- surgery in the upper quadrant region <12 months prior to the study
- skin or medical conditions that prevents from receiving tactile stimuli on the shoulder
- neurological or motor disorders including a diagnosis of dyslexia or difficulty performing a rapid naming task
- visually and mental health conditions that precludes successful participation.
Sites / Locations
- University of Valencia
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
CNS-focused treatment
Standard Care Treatment
Arm Description
Group of subjects receiving a 10 week CNS (Central Nervous System) -focused treatment program for frozen shoulder in addition to 5 days per week home treatment program
Group of subjects receiving a 10 week standard care treatment program for frozen shoulder in addition to 5 days per week home treatment program based on conventional physiotherapy
Outcomes
Primary Outcome Measures
shoulder pain-related disability questionnaire (SPADI)
The SPADI is a 13-items shoulder function index assessing pain and disability related to shoulder dysfunction. Each item is scored by a numeric rate scale ranging from 0 (no pain/no difficulty) to 10 (worst pain imaginable/so difficult it required help). The total score ranges from 0 to 100 points where a higher score indicates greater disability.
shoulder pain-related disability questionnaire (SPADI)
The SPADI is a 13-items shoulder function index assessing pain and disability related to shoulder dysfunction. Each item is scored by a numeric rate scale ranging from 0 (no pain/no difficulty) to 10 (worst pain imaginable/so difficult it required help). The total score ranges from 0 to 100 points where a higher score indicates greater disability.
shoulder pain-related disability questionnaire (SPADI)
The SPADI is a 13-items shoulder function index assessing pain and disability related to shoulder dysfunction. Each item is scored by a numeric rate scale ranging from 0 (no pain/no difficulty) to 10 (worst pain imaginable/so difficult it required help). The total score ranges from 0 to 100 points where a higher score indicates greater disability.
shoulder pain-related disability questionnaire (SPADI)
The SPADI is a 13-items shoulder function index assessing pain and disability related to shoulder dysfunction. Each item is scored by a numeric rate scale ranging from 0 (no pain/no difficulty) to 10 (worst pain imaginable/so difficult it required help). The total score ranges from 0 to 100 points where a higher score indicates greater disability.
Secondary Outcome Measures
Numeric Pain Rating Scale
a valid and reliable measure of shoulder pain. Participants will be presented with numerical rating scales anchored with 0 ("no pain") and 10 ("pain as bad as you can imagine").
Numeric Pain Rating Scale
a valid and reliable measure of shoulder pain. Participants will be presented with numerical rating scales anchored with 0 ("no pain") and 10 ("pain as bad as you can imagine").
Numeric Pain Rating Scale
a valid and reliable measure of shoulder pain. Participants will be presented with numerical rating scales anchored with 0 ("no pain") and 10 ("pain as bad as you can imagine").
Numeric Pain Rating Scale
a valid and reliable measure of shoulder pain. Participants will be presented with numerical rating scales anchored with 0 ("no pain") and 10 ("pain as bad as you can imagine").
Goniometric assessment of active shoulder ROM (range of motion)
Degrees of active range of motion
Goniometric assessment of active shoulder ROM (range of motion)
Degrees of active range of motion
Goniometric assessment of active shoulder ROM (range of motion)
Degrees of active range of motion
Goniometric assessment of active shoulder ROM (range of motion)
Degrees of active range of motion
Two point discrimination threshold
Two point discrimination threshold measured at one standardize site on the affected shoulder (5cm distal to the lateral border of the acromion) 33, following an established protocol
Two point discrimination threshold
Two point discrimination threshold measured at one standardize site on the affected shoulder (5cm distal to the lateral border of the acromion) 33, following an established protocol
Two point discrimination threshold
Two point discrimination threshold measured at one standardize site on the affected shoulder (5cm distal to the lateral border of the acromion) 33, following an established protocol
Two point discrimination threshold
Two point discrimination threshold measured at one standardize site on the affected shoulder (5cm distal to the lateral border of the acromion) 33, following an established protocol
Laterality judgement accuracy
Laterality judgement accuracy using the NOI Recognise online program (www.noigroup.com) and following and established protocol
Laterality judgement accuracy
Laterality judgement accuracy using the NOI Recognise online program (www.noigroup.com) and following and established protocol
Laterality judgement accuracy
Laterality judgement accuracy using the NOI Recognise online program (www.noigroup.com) and following and established protocol
Laterality judgement accuracy
Laterality judgement accuracy using the NOI Recognise online program (www.noigroup.com) and following and established protocol
The Spanish version of the Tampa Scale of Kinesophobia (TSK-11)
The TSK-11 is an 11-item questionnaire assessing fear of movement or fear of (re)injury during movement. It is comprised of 11 items each ranged on a 4-point scale with the end points (1) "totally agree" and (4) "totally disagree" (range: 11-44). Higher scores indicate more fear-avoidance behavior.
The Spanish version of the Tampa Scale of Kinesophobia
The TSK-11 is an 11-item questionnaire assessing fear of movement or fear of (re)injury during movement. It is comprised of 11 items each ranged on a 4-point scale with the end points (1) "totally agree" and (4) "totally disagree" (range: 11-44). Higher scores indicate more fear-avoidance behavior.
The Spanish version of the Tampa Scale of Kinesophobia
The TSK-11 is an 11-item questionnaire assessing fear of movement or fear of (re)injury during movement. It is comprised of 11 items each ranged on a 4-point scale with the end points (1) "totally agree" and (4) "totally disagree" (range: 11-44). Higher scores indicate more fear-avoidance behavior.
The Spanish version of the Tampa Scale of Kinesophobia
The TSK-11 is an 11-item questionnaire assessing fear of movement or fear of (re)injury during movement. It is comprised of 11 items each ranged on a 4-point scale with the end points (1) "totally agree" and (4) "totally disagree" (range: 11-44). Higher scores indicate more fear-avoidance behavior.
The Patient Specific Functional Scale
A list of activities and movements is shown to the patients and they are asked to identify the activities that he/she experience difficulty with because of his/her complaints in the shoulder. The patient selects the 3 most important activities and rank them by degree of importance from 0 (no difficulty at all) to 10 (impossible). The total score range from 0 to 30. Higher score indicates higher difficulty in performance on daily activities.
The Patient Specific Functional Scale
A list of activities and movements is shown to the patients and they are asked to identify the activities that he/she experience difficulty with because of his/her complaints in the shoulder. The patient selects the 3 most important activities and rank them by degree of importance from 0 (no difficulty at all) to 10 (impossible). The total score range from 0 to 30. Higher score indicates higher difficulty in performance on daily activities.
The Patient Specific Functional Scale
A list of activities and movements is shown to the patients and they are asked to identify the activities that he/she experience difficulty with because of his/her complaints in the shoulder. The patient selects the 3 most important activities and rank them by degree of importance from 0 (no difficulty at all) to 10 (impossible). The total score range from 0 to 30. Higher score indicates higher difficulty in performance on daily activities.
The Patient Specific Functional Scale
A list of activities and movements is shown to the patients and they are asked to identify the activities that he/she experience difficulty with because of his/her complaints in the shoulder. The patient selects the 3 most important activities and rank them by degree of importance from 0 (no difficulty at all) to 10 (impossible). The total score range from 0 to 30. Higher score indicates higher difficulty in performance on daily activities.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03320200
Brief Title
A Central Nervous System Focused Treatment Approach for Frozen Shoulder
Official Title
A Central Nervous System Focused Treatment Approach for People With Frozen Shoulder: Protocol for a Randomised Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
July 2022
Overall Recruitment Status
Completed
Study Start Date
October 1, 2017 (Actual)
Primary Completion Date
February 18, 2021 (Actual)
Study Completion Date
February 18, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Valencia
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study is to compare the effectiveness of a CNS-directed treatment program versus a standard medical and physiotherapy care program on outcomes in participants with FS.Participants will be randomized to receive either a 10 weeks CNS-focused treatment program or standard medical and physiotherapy care.To evaluate the results of the interventions, the subjects will be assessed at the beginning, at the end of the treatment program (week 10) and at 3 and 6 months of follow-up.
Detailed Description
The aim of this study is to compare the effectiveness of a CNS-directed treatment program versus a standard medical and physiotherapy care program on outcomes in participants with Frozen Shoulder (FS). It will consist of a randomized double-blind clinical trial (both participants and evaluators). The sample will consist of subjects with primary or idiopathic FS.
Once the sample is selected, participants will be randomly assigned to receive either a CNS-centered treatment program or a standard physiotherapy program. The CNS-centered treatment program will last for 10 weeks, conducted in 60-minute sessions on a weekly basis. In addition, participants in this group will complete a home treatment program for 30 minutes, five times a week. On the other hand, subjects assigned to the standard physiotherapy group will receive a 10-session treatment program, such as the CNS-centered treatment group. This standard treatment will include one corticosteroid infiltration provided in the early acute stage followed by a multimodal physiotherapy program including analgesic modalities (e.g. TENS, cryotherapy) and exercise and manual therapy techniques addressing the specific mobility deficits of each patient. Physiotherapists will be instructed not to include interventions that were similar to those used in the group receiving the CNS-focused protocol (e.g. using mirrors or imagined movements) and to include a home program that involves a training load comparable to that in the other group. Adherence to both interventions will be monitored using an individual treatment diary where the time of day and duration of each clinic and home session will be recorded To evaluate the results of the interventions, the subjects will be assessed at the beginning, at the end of the treatment program (week 10) and at 3 and 6 months of follow-up.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Adhesive Capsulitis of Shoulder, Frozen Shoulder
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
34 (Actual)
8. Arms, Groups, and Interventions
Arm Title
CNS-focused treatment
Arm Type
Experimental
Arm Description
Group of subjects receiving a 10 week CNS (Central Nervous System) -focused treatment program for frozen shoulder in addition to 5 days per week home treatment program
Arm Title
Standard Care Treatment
Arm Type
Experimental
Arm Description
Group of subjects receiving a 10 week standard care treatment program for frozen shoulder in addition to 5 days per week home treatment program based on conventional physiotherapy
Intervention Type
Other
Intervention Name(s)
CNS-focused treatment
Other Intervention Name(s)
graded motor and sensory imagery traininng
Intervention Description
The CNS-focused treatment will last for 10 weeks, conducted in 60-minute sessions on a weekly basis. In addition, participants in this group will complete a home treatment program for 30 minutes, five times a week.
Intervention Type
Other
Intervention Name(s)
Standard Care Treatment
Other Intervention Name(s)
Conventional physiotherapy treatment
Intervention Description
The standard physiotherapy group will receive a 10-session treatment program that will include one corticosteroid infiltration provided in the early acute stage followed by a multimodal physiotherapy program including analgesic modalities (e.g. TENS, cryotherapy) and exercise and manual therapy techniques addressing the specific mobility deficits of each patient. This program also include a home treatment based on conventional physiotherapy that involves a training load comparable to that in the CNS-focused group.
Primary Outcome Measure Information:
Title
shoulder pain-related disability questionnaire (SPADI)
Description
The SPADI is a 13-items shoulder function index assessing pain and disability related to shoulder dysfunction. Each item is scored by a numeric rate scale ranging from 0 (no pain/no difficulty) to 10 (worst pain imaginable/so difficult it required help). The total score ranges from 0 to 100 points where a higher score indicates greater disability.
Time Frame
Baseline
Title
shoulder pain-related disability questionnaire (SPADI)
Description
The SPADI is a 13-items shoulder function index assessing pain and disability related to shoulder dysfunction. Each item is scored by a numeric rate scale ranging from 0 (no pain/no difficulty) to 10 (worst pain imaginable/so difficult it required help). The total score ranges from 0 to 100 points where a higher score indicates greater disability.
Time Frame
Change from baseline SPADI at 10 weeks
Title
shoulder pain-related disability questionnaire (SPADI)
Description
The SPADI is a 13-items shoulder function index assessing pain and disability related to shoulder dysfunction. Each item is scored by a numeric rate scale ranging from 0 (no pain/no difficulty) to 10 (worst pain imaginable/so difficult it required help). The total score ranges from 0 to 100 points where a higher score indicates greater disability.
Time Frame
Change from baseline SPADI at 3 months
Title
shoulder pain-related disability questionnaire (SPADI)
Description
The SPADI is a 13-items shoulder function index assessing pain and disability related to shoulder dysfunction. Each item is scored by a numeric rate scale ranging from 0 (no pain/no difficulty) to 10 (worst pain imaginable/so difficult it required help). The total score ranges from 0 to 100 points where a higher score indicates greater disability.
Time Frame
Change from baseline SPADI at 6 months
Secondary Outcome Measure Information:
Title
Numeric Pain Rating Scale
Description
a valid and reliable measure of shoulder pain. Participants will be presented with numerical rating scales anchored with 0 ("no pain") and 10 ("pain as bad as you can imagine").
Time Frame
Baseline
Title
Numeric Pain Rating Scale
Description
a valid and reliable measure of shoulder pain. Participants will be presented with numerical rating scales anchored with 0 ("no pain") and 10 ("pain as bad as you can imagine").
Time Frame
Change from baseline Numeric Rating Pain Scale at 10 weeks
Title
Numeric Pain Rating Scale
Description
a valid and reliable measure of shoulder pain. Participants will be presented with numerical rating scales anchored with 0 ("no pain") and 10 ("pain as bad as you can imagine").
Time Frame
Change from baseline Numeric Rating Pain Scale at 3 months
Title
Numeric Pain Rating Scale
Description
a valid and reliable measure of shoulder pain. Participants will be presented with numerical rating scales anchored with 0 ("no pain") and 10 ("pain as bad as you can imagine").
Time Frame
Change from baseline Numeric Rating Pain Scale at 6 months
Title
Goniometric assessment of active shoulder ROM (range of motion)
Description
Degrees of active range of motion
Time Frame
Baseline
Title
Goniometric assessment of active shoulder ROM (range of motion)
Description
Degrees of active range of motion
Time Frame
Change from baseline ROM at 10 weeks
Title
Goniometric assessment of active shoulder ROM (range of motion)
Description
Degrees of active range of motion
Time Frame
Change from baseline ROM at 3 months
Title
Goniometric assessment of active shoulder ROM (range of motion)
Description
Degrees of active range of motion
Time Frame
Change from baseline ROM at 6 months
Title
Two point discrimination threshold
Description
Two point discrimination threshold measured at one standardize site on the affected shoulder (5cm distal to the lateral border of the acromion) 33, following an established protocol
Time Frame
Baseline
Title
Two point discrimination threshold
Description
Two point discrimination threshold measured at one standardize site on the affected shoulder (5cm distal to the lateral border of the acromion) 33, following an established protocol
Time Frame
Change from baseline two point discrimination threshold at 10 weeks
Title
Two point discrimination threshold
Description
Two point discrimination threshold measured at one standardize site on the affected shoulder (5cm distal to the lateral border of the acromion) 33, following an established protocol
Time Frame
Change from baseline two point discrimination threshold at 3 months
Title
Two point discrimination threshold
Description
Two point discrimination threshold measured at one standardize site on the affected shoulder (5cm distal to the lateral border of the acromion) 33, following an established protocol
Time Frame
Change from baseline two point discrimination threshold at 6 months
Title
Laterality judgement accuracy
Description
Laterality judgement accuracy using the NOI Recognise online program (www.noigroup.com) and following and established protocol
Time Frame
Baseline
Title
Laterality judgement accuracy
Description
Laterality judgement accuracy using the NOI Recognise online program (www.noigroup.com) and following and established protocol
Time Frame
Change from baseline laterality judgement accuracy at 10 weeks
Title
Laterality judgement accuracy
Description
Laterality judgement accuracy using the NOI Recognise online program (www.noigroup.com) and following and established protocol
Time Frame
Change from baseline laterality judgement accuracy at 3 months
Title
Laterality judgement accuracy
Description
Laterality judgement accuracy using the NOI Recognise online program (www.noigroup.com) and following and established protocol
Time Frame
Change from baseline laterality judgement accuracy at 6 months
Title
The Spanish version of the Tampa Scale of Kinesophobia (TSK-11)
Description
The TSK-11 is an 11-item questionnaire assessing fear of movement or fear of (re)injury during movement. It is comprised of 11 items each ranged on a 4-point scale with the end points (1) "totally agree" and (4) "totally disagree" (range: 11-44). Higher scores indicate more fear-avoidance behavior.
Time Frame
Baseline
Title
The Spanish version of the Tampa Scale of Kinesophobia
Description
The TSK-11 is an 11-item questionnaire assessing fear of movement or fear of (re)injury during movement. It is comprised of 11 items each ranged on a 4-point scale with the end points (1) "totally agree" and (4) "totally disagree" (range: 11-44). Higher scores indicate more fear-avoidance behavior.
Time Frame
Change from baseline Tampa Scale of Kinesophobia at 10 weeks
Title
The Spanish version of the Tampa Scale of Kinesophobia
Description
The TSK-11 is an 11-item questionnaire assessing fear of movement or fear of (re)injury during movement. It is comprised of 11 items each ranged on a 4-point scale with the end points (1) "totally agree" and (4) "totally disagree" (range: 11-44). Higher scores indicate more fear-avoidance behavior.
Time Frame
Change from baseline Tampa Scale of Kinesophobia at 3 months
Title
The Spanish version of the Tampa Scale of Kinesophobia
Description
The TSK-11 is an 11-item questionnaire assessing fear of movement or fear of (re)injury during movement. It is comprised of 11 items each ranged on a 4-point scale with the end points (1) "totally agree" and (4) "totally disagree" (range: 11-44). Higher scores indicate more fear-avoidance behavior.
Time Frame
Change from baseline Tampa Scale of Kinesophobia at 6 months
Title
The Patient Specific Functional Scale
Description
A list of activities and movements is shown to the patients and they are asked to identify the activities that he/she experience difficulty with because of his/her complaints in the shoulder. The patient selects the 3 most important activities and rank them by degree of importance from 0 (no difficulty at all) to 10 (impossible). The total score range from 0 to 30. Higher score indicates higher difficulty in performance on daily activities.
Time Frame
Baseline
Title
The Patient Specific Functional Scale
Description
A list of activities and movements is shown to the patients and they are asked to identify the activities that he/she experience difficulty with because of his/her complaints in the shoulder. The patient selects the 3 most important activities and rank them by degree of importance from 0 (no difficulty at all) to 10 (impossible). The total score range from 0 to 30. Higher score indicates higher difficulty in performance on daily activities.
Time Frame
Change from baseline Patient Specific Functional Scale at 10 weeks
Title
The Patient Specific Functional Scale
Description
A list of activities and movements is shown to the patients and they are asked to identify the activities that he/she experience difficulty with because of his/her complaints in the shoulder. The patient selects the 3 most important activities and rank them by degree of importance from 0 (no difficulty at all) to 10 (impossible). The total score range from 0 to 30. Higher score indicates higher difficulty in performance on daily activities.
Time Frame
Change from baseline Patient Specific Functional Scale at 3 months
Title
The Patient Specific Functional Scale
Description
A list of activities and movements is shown to the patients and they are asked to identify the activities that he/she experience difficulty with because of his/her complaints in the shoulder. The patient selects the 3 most important activities and rank them by degree of importance from 0 (no difficulty at all) to 10 (impossible). The total score range from 0 to 30. Higher score indicates higher difficulty in performance on daily activities.
Time Frame
Change from baseline Patient Specific Functional Scale at 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Primary or idiopathic Frozen Shoulder (FS), defined as FS not associated with a systemic condition or history of injury
greater than 50% reduction in passive external rotation when compared to the uninvolved shoulder or less than 30° of external rotation
range of motion loss of greater than 25% in at least two movement planes in comparison to the uninvolved shoulder
pain and restricted movement present for at least one month reaching a plateau or worsening
normal shoulder X-rays (with the exception of osteopenia of the humeral head and calcific tendinosis)
Exclusion Criteria:
Locked dislocations, arthritis, fractures or avascular necrosis on radiographs
surgery in the upper quadrant region <12 months prior to the study
skin or medical conditions that prevents from receiving tactile stimuli on the shoulder
neurological or motor disorders including a diagnosis of dyslexia or difficulty performing a rapid naming task
visually and mental health conditions that precludes successful participation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Enrique Lluch, PhD
Organizational Affiliation
Physiotherapy Department University of Valencia
Official's Role
Study Director
Facility Information:
Facility Name
University of Valencia
City
Valencia
ZIP/Postal Code
46010
Country
Spain
12. IPD Sharing Statement
Citations:
PubMed Identifier
21350034
Citation
Wand BM, O'Connell NE, Di Pietro F, Bulsara M. Managing chronic nonspecific low back pain with a sensorimotor retraining approach: exploratory multiple-baseline study of 3 participants. Phys Ther. 2011 Apr;91(4):535-46. doi: 10.2522/ptj.20100150. Epub 2011 Feb 24.
Results Reference
result
PubMed Identifier
28483657
Citation
Louw A, Puentedura EJ, Reese D, Parker P, Miller T, Mintken PE. Immediate Effects of Mirror Therapy in Patients With Shoulder Pain and Decreased Range of Motion. Arch Phys Med Rehabil. 2017 Oct;98(10):1941-1947. doi: 10.1016/j.apmr.2017.03.031. Epub 2017 May 5.
Results Reference
result
PubMed Identifier
16874790
Citation
Moseley GL. Do training diaries affect and reflect adherence to home programs? Arthritis Rheum. 2006 Aug 15;55(4):662-4. doi: 10.1002/art.22086. No abstract available.
Results Reference
result
PubMed Identifier
22133255
Citation
Louw A, Diener I, Butler DS, Puentedura EJ. The effect of neuroscience education on pain, disability, anxiety, and stress in chronic musculoskeletal pain. Arch Phys Med Rehabil. 2011 Dec;92(12):2041-56. doi: 10.1016/j.apmr.2011.07.198.
Results Reference
result
Citation
Moseley G, Butler D, Beames T, Giles T. The graded motor imagery handbook. Adelaide: Noigroup Publishing; 2012.
Results Reference
result
PubMed Identifier
28715302
Citation
Desroches G, Desmeules F, Gagnon DH. Characterization of humeral head displacements during dynamic glenohumeral neuromuscular control exercises using quantitative ultrasound imaging: A feasibility study. Musculoskelet Sci Pract. 2017 Jun;29:150-154. doi: 10.1016/j.msksp.2016.12.004. Epub 2016 Dec 11.
Results Reference
result
PubMed Identifier
17910930
Citation
Mottram SL, Woledge RC, Morrissey D. Motion analysis study of a scapular orientation exercise and subjects' ability to learn the exercise. Man Ther. 2009 Feb;14(1):13-8. doi: 10.1016/j.math.2007.07.008. Epub 2007 Oct 1.
Results Reference
result
PubMed Identifier
32148332
Citation
Mena-Del Horno S, Balasch-Bernat M, Duenas L, Reis F, Louw A, Lluch E. Laterality judgement and tactile acuity in patients with frozen shoulder: A cross-sectional study. Musculoskelet Sci Pract. 2020 Jun;47:102136. doi: 10.1016/j.msksp.2020.102136. Epub 2020 Feb 24.
Results Reference
derived
PubMed Identifier
31409380
Citation
Lluch-Girbes E, Duenas L, Mena-Del Horno S, Luque-Suarez A, Navarro-Ledesma S, Louw A. A central nervous system-focused treatment approach for people with frozen shoulder: protocol for a randomized clinical trial. Trials. 2019 Aug 13;20(1):498. doi: 10.1186/s13063-019-3585-z.
Results Reference
derived
Learn more about this trial
A Central Nervous System Focused Treatment Approach for Frozen Shoulder
We'll reach out to this number within 24 hrs